How antibiotics can make us sick: the less obvious adverse effects of antimicrobial chemotherapy

Stephanie J Dancer1

  • 1Scottish Centre for Infection and Environmental Health, Glasgow, UK. stephanie.dancer@scieh.csa.scot.nhs.uk <stephanie.dancer@scieh.csa.scot.nhs.uk>

Insights

Antimicrobial drugs can cause side-effects and lead to resistant infections. Understanding these risks is crucial for appropriate antibiotic use and preventing the spread of antimicrobial resistance.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Clinical Pharmacology

Background:

  • Antimicrobial agents are vital for treating infections, but their use is associated with known side-effects.
  • Clinicians often overlook less obvious adverse events, such as the overgrowth of resistant microorganisms.
  • This overgrowth can lead to secondary infections and contribute to global antimicrobial resistance.

Purpose of the Study:

  • To highlight the under-recognized adverse events associated with antimicrobial use.
  • To emphasize the link between antimicrobial consumption, microbial resistance, and enhanced pathogenicity.
  • To underscore the importance of microbiological understanding in appropriate antibiotic prescribing.

Main Methods:

  • Literature review and synthesis of existing data on antimicrobial side-effects and resistance.
  • Analysis of the molecular mechanisms by which antibiotic exposure may enhance microbial virulence.
  • Discussion of clinical and environmental implications of antimicrobial overconsumption.

Main Results:

  • Antimicrobial use can lead to the proliferation of resistant organisms, potentially causing more severe secondary infections.
  • Molecular alterations in microorganisms exposed to antibiotics may increase their virulence.
  • Inappropriate prescribing, driven by a lack of microbiological insight, exacerbates these issues.

Conclusions:

  • The less obvious consequences of antimicrobial use, including resistance and enhanced pathogenicity, are often unrecognized in routine clinical practice.
  • Enhanced understanding of microbiology and environmental impact is essential for responsible antimicrobial stewardship.
  • Addressing these overlooked factors is critical to combatting the growing threat of antimicrobial resistance worldwide.

Related Concept Videos

Antibiotic Selection00:57

Antibiotic Selection

Overview
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Microbiota Modulation by Antibiotics01:21

Microbiota Modulation by Antibiotics

Antibiotics have revolutionized modern medicine by saving countless lives from bacterial infections. However, their widespread use has inadvertently harmed the delicate balance of the human gut microbiota. The gut microbiota, a complex community of bacteria, archaea, viruses, and fungi, plays a vital role in regulating metabolism, immune responses, and maintaining intestinal health. Antibiotics, especially broad-spectrum types, disrupt this ecosystem by eradicating both harmful and beneficial...
Inhibitors of Bacterial Protein Synthesis01:25

Inhibitors of Bacterial Protein Synthesis

Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
Inhibitors of Bacterial DNA Synthesis01:28

Inhibitors of Bacterial DNA Synthesis

Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These antibiotics are selectively...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...